Kausik K. Ray

机构：Public Health England, Imperial College London · ORCID：0000-0003-0508-0954

发表论文 814 篇 · 总被引 91455 次 · h-index 121

代表论文

• Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients (2025 · Journal of the American College of Cardiology · 被引 34)
• Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis (2025 · Atherosclerosis · 被引 22)
• International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE study (2025 · European Journal of Preventive Cardiology · 被引 12)
• Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease (2025 · The Journal of Prevention of Alzheimer s Disease · 被引 11)
• Factors associated with elevated high-sensitivity C-reactive protein levels in individuals with atherosclerotic cardiovascular disease in the USA and the UK (2025 · European Journal of Preventive Cardiology · 被引 7)
• Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study (2025 · European Journal of Preventive Cardiology · 被引 6)